Hidradenitis Suppurativa (HS) Recruiting Phase 4 Trials for Adalimumab (DB00051)

Also known as: Hidradenitis Suppurativa / Hidradenitis / Sweat gland inflammation / Acne inversa

IndicationStatusPhase
DBCOND0054533 (Hidradenitis Suppurativa (HS))Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03221621Cost-effectiveness of Adalimumab and Surgery vs Adalimumab in HSTreatment